First batch of H1N1 vaccine to be sent to US

A flu-vaccine maker will send trial material to the US this week to test an inoculation against H1N1.

  • If a person becomes sick with H1N1, antiviral drugs can make the illness milder and make the patient feel bettImage Credit:Gulf News Archive
  • According to the Centers for Disease Control and Prevention, in humans the symptoms of H1N1 are similar to thoImage Credit:Gulf News Archive
  • The flu spreads between humans through coughing or sneezing and people touching something with the virus on itImage Credit:Gulf News Archive
  • Fatalities are more likely in young children and the elderly. Image Credit:Gulf News Archive
  • Symptoms include fever, cough, sore throat, body aches, headache, chills and fatigue. Image Credit:Gulf News Archive
  • Recommendations to prevent spread of the virus among humans include using standard infection control against iImage Credit:Gulf News Archive
  • Staying away from other people who might be infected and avoiding large gatherings, spreading out a little at Image Credit:Gulf News Archive
Gulf News

Melbourne: CSL Ltd., the only flu-vaccine maker in the Southern Hemisphere, will send trial material to the US this week to test an inoculation against swine flu, Rachel David, a spokeswoman for the Melbourne-based company, said on Tuesday.

CSL will stockpile bulk antigen for use in pandemic flu vaccine until the material is requested by the US Department of Health and Human Services, David said.

Meanwhile, US is readying its first human trials for the experimental vaccine to protect against the H1N1 swine flu virus, officials announced Wednesday.

Two possible vaccines will be tested at eight institutions around the country under the auspices of the National Institute of Allergy and Infectious Diseases (NIAID)

On Tuesday it was revealed that two Australian biotechnology companies have started inoculating adult volunteers in the world's first H1N1 swine flu vaccine trials.

Those trials, as well as the trials planned in the US, hope to produce an effective shot against the virus that has so far killed more than 700 people worldwide.

In the United States, several trials will be conducted concurrently, officials said.